{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T20:43:08Z","timestamp":1776976988621,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":3657,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1111\/jth.12026","type":"journal-article","created":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T12:51:12Z","timestamp":1350391872000},"page":"2462-2469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effect of assay specificity on the association of urine 11\u2010dehydro thromboxane B2 determination with cardiovascular risk"],"prefix":"10.1016","volume":"10","author":[{"given":"M.T.","family":"OLSON","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.S.","family":"KICKLER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"LAWSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.C.","family":"MCLEAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"JANI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.A.","family":"FITZGERALD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"RADE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12026_bb0010","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1073\/pnas.72.8.2994","article-title":"Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides","volume":"72","author":"Hamberg","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/jth.12026_bb0015","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/315511a0","article-title":"Synthesis and structure of the platelet aggregation factor thromboxane A2","volume":"315","author":"Bhagwat","year":"1985","journal-title":"Nature"},{"key":"10.1111\/jth.12026_bb0020","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"key":"10.1111\/jth.12026_bb0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative overview of randomised trials of antiplatelet therapy\u2013I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/jth.12026_bb0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","article-title":"Aspirin \u201cresistance\u201d and risk of cardiovascular morbidity: systematic review and meta\u2010analysis","volume":"336","author":"Krasopoulos","year":"2008","journal-title":"BMJ"},{"key":"10.1111\/jth.12026_bb0035","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/archinte.167.15.1593","article-title":"Association of laboratory\u2010defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta\u2010analysis","volume":"167","author":"Snoep","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1111\/jth.12026_bb0040","doi-asserted-by":"crossref","first-page":"8384","DOI":"10.1016\/S0021-9258(19)68855-1","article-title":"Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites","volume":"256","author":"Roberts","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12026_bb0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0005-2760(87)90233-5","article-title":"Radioimmunoassay of 11\u2010dehydrothromboxane B2 in human plasma and urine","volume":"918","author":"Ciabattoni","year":"1987","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/jth.12026_bb0050","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1373\/clinchem.2007.101014","article-title":"Aspirin responsiveness in healthy volunteers measured with multiple assay platforms","volume":"54","author":"Karon","year":"2008","journal-title":"Clin Chem"},{"key":"10.1111\/jth.12026_bb0055","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin\u2010resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/jth.12026_bb0060","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/CIRCULATIONAHA.108.768283","article-title":"Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid. determinants and effect on cardiovascular risk","volume":"118","author":"Eikelboom","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/jth.12026_bb0065","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jacc.2010.08.650","article-title":"Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery","volume":"57","author":"Gluckman","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12026_bb0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF03256268","article-title":"AspirinWorks: a new immunologic diagnostic test for monitoring aspirin effect","volume":"12","author":"Geske","year":"2008","journal-title":"Mol Diagn Ther"},{"key":"10.1111\/jth.12026_bb0075","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1538-7836.2009.03526.x","article-title":"Effect of anti\u2010platelet factor\u20104\/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery","volume":"7","author":"Gluckman","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12026_bb0080","first-page":"877","article-title":"Relative importance of patient, procedural and anatomic risk factors for early vein graft thrombosis after coronary artery bypass graft surgery","volume":"52","author":"McLean","year":"2011","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1111\/jth.12026_bb0085","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.thromres.2009.04.016","article-title":"Clinical and laboratory factors associated with shear\u2010dependent platelet hyper\u2010reactivity in patients on chronic aspirin therapy","volume":"126","author":"Nazarian","year":"2009","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12026_bb0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0003-2697(81)90237-2","article-title":"Enzymatic preparation of carboxyl oxygen\u201018 labeled prostaglandin F2 alpha and utility for quantitative mass spectrometry","volume":"111","author":"Pickett","year":"1981","journal-title":"Anal Biochem"},{"key":"10.1111\/jth.12026_bb0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"10.1111\/jth.12026_bb0100","unstructured":"Cayman Chemical. Product Information:11\u2010dehydro Thromboxane B2 EIA Antiserum. [419502]. 10\u201015\u20102010."},{"key":"10.1111\/jth.12026_bb0105","unstructured":"Caymen Chemical. Product Information:11\u2010dehydro Thromboxane B2 Monoclonal Antibody. [419512]. 2\u20107\u20102012."},{"key":"10.1111\/jth.12026_bb0110","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/0003-4975(95)90024-1","article-title":"Predictors of early saphenous vein aortocoronary bypass graft occlusion. The GESIC Study Group","volume":"56","author":"Paz","year":"1993","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jth.12026_bb0115","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/S0022-5223(03)01276-5","article-title":"Factors affecting saphenous vein graft patency: clinical and angiographic study in 1402 symptomatic patients operated on between 1977 and 1999","volume":"126","author":"Shah","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/jth.12026_bb0120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0090-6980(93)90117-P","article-title":"Urinary excretion and origin of 11\u2010dehydro\u20102,3\u2010dinor\u2010thromboxane B2 in man","volume":"45","author":"Chiabrando","year":"1993","journal-title":"Prostaglandins"},{"key":"10.1111\/jth.12026_bb0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0163-7827(94)90025-6","article-title":"Beta\u2010oxidation of eicosanoids","volume":"33","author":"Diczfalusy","year":"1994","journal-title":"Prog Lipid Res"},{"key":"10.1111\/jth.12026_bb0130","first-page":"F77","article-title":"Renal metabolism and urinary excretion of thromboxane B2 in the rat","volume":"257","author":"Benigni","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1111\/jth.12026_bb0135","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ki.1992.217","article-title":"Thromboxane synthesis and action within the kidney","volume":"41","author":"Remuzzi","year":"1992","journal-title":"Kidney Int"},{"key":"10.1111\/jth.12026_bb0140","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0049-3848(87)90103-4","article-title":"Paired analysis of urinary thromboxane B2 metabolites in humans","volume":"47","author":"Catella","year":"1987","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12026_bb0145","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0003-2697(86)90247-2","article-title":"Long\u2010lived enzymatic metabolites of thromboxane B2 in the human circulation","volume":"155","author":"Lawson","year":"1986","journal-title":"Anal Biochem"},{"key":"10.1111\/jth.12026_bb0150","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1073\/pnas.83.16.5861","article-title":"11\u2010Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation","volume":"83","author":"Catella","year":"1986","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12026","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12026","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622065412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622065412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12026\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:56:55Z","timestamp":1761533815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622065412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1538783622065412"],"URL":"https:\/\/doi.org\/10.1111\/jth.12026","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of assay specificity on the association of urine 11\u2010dehydro thromboxane B2 determination with cardiovascular risk","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}